KEEP UP WITH THE LATEST IN INDUSTRY NEWS!
From news about new medicines, pharmacy business insights, and the pharmaceutical industry in general—this is your source!
DrugTopics articles
- Government Dedicates Nearly $200 Million to Contain US Bird Flu Outbreak May 16, 2024Over half of the money is set to assist the overall effort to stop the virus, while the remaining funds will go to dairy farms affected by the bird flu outbreak.
- Once-Weekly Insulin for T2D Shows Positive Topline Results in Phase 3 Clinical Trial Program May 16, 2024Efsitora (efsitora alfa) from Eli Lilly met its primary endpoint of non-inferior A1C reduction compared to insulin degludec and insulin glargine in 2 phase 3 studies.
- Q&A: How Coffee Helped This Pharmacy Improve Front-End Sales May 16, 2024Chris Schaffner, PharmD, owner of Schaffner Pharmacy and Apothecary Coffee in Sedro-Woolley, Washington, sat down with Drug Topics to discuss his joint business venture.
- Pharmacists Can Promote Sun Safety Through Education, Product Accessibility May 16, 2024Pharmacists must take a multifaceted approach to educating patients on sun safety that extends beyond sunscreen counseling, according to Colleen McCabe, PharmD, BCOP.
- Quiz: Understanding Food Allergies May 16, 2024Test your knowledge of food allergies.
- How Community Pharmacists Can Personalize Skin Awareness Counseling May 15, 2024Colleen McCabe, PharmD, BCOP, emphasizes the importance of a proactive and tailored approach for pharmacists educating patients on skin cancer risks specific to their communities.
- T1D Prevalence Increased Among US Adults Aged 45 to 64 May 15, 2024Type 1 diabetes (T1D), which once predominantly affected children, is increasingly affecting older adults in the US, with prevalence rates peaking in those aged 45 to 64, according to recent research.
- Walgreens to Start Selling its Own OTC Naloxone Nasal Spray May 15, 2024The company’s version of the opioid overdose medication will be $10 cheaper than branded products and is set to be available in stores later this month.
- The Flawless Fallacy: A Pharmacist’s Guide to Skin Care in the Digital Age May 15, 2024Cutting through the noise of social media is key when educating patients on how to make better choices for their skin.
- Reviewing Efficacy, Safety of Weight Loss Therapies in T1D May 15, 2024Different weight loss therapies provide a wide range of benefits to patients with T1D—but they have some potential adverse effects.
Pharmacy Times articles
- Pharmacist Discusses Connecting Patients With Cancer to Clinical Trials at Mayo Clinic May 16, 2024Candy Peskey highlights the necessary role of oncology pharmacists in patient care and enrollment in clinical trials.
- Expert Discusses the Impact of Medicare Drug Pricing Reforms on the Pharmaceutical Industry May 16, 2024Access to certain drugs may be limited through tighter formulary controls and utilization management by Medicare Part D plans dealing with higher costs
- Mayo Clinic Oncology Pharmacist Discusses Bridging Clinical Research and Pharmacy Practice May 16, 2024Scott Soefje highlights how oncology pharmacists can advance patient-centered care and drive innovation in clinical research.
- Adiposity in Childhood May Affect the Risk of Developing Breast Cancer in Adulthood May 16, 2024The study data demonstrate that higher adiposity in childhood results in less dense breast tissue forming, reducing the risk of breast cancer.
- Collaborating with Other Care Providers to Optimize Outcomes for Patients Receiving Bispecifics May 16, 2024The expert panel explores the importance of communication and collaboration among care providers when patients with multiple myeloma who are receiving treatment with bispecific antibodies navigate transitions of care to and from various healthcare settings.
- Identifying Patients Who Are Candidates for Bispecifics and Referring Patients for Care May 16, 2024Medical professionals share insights on treatment considerations and patient selection for bispecific antibody therapy and the process for referring patients to other institutions for care.
- FDA Grants Accelerated Approval for Liso-Cel in Patients With Relapsed or Refractory Follicular Lymphoma May 16, 2024The indication is for adult patients who have received at least 2 prior lines of systemic therapy and is based on the response rate and duration of response shown in a phase 2 trial.
- Advise Patients About Travel Vaccines May 16, 2024As Summer Approaches, Many Will Be Planning Vacations and Trips Abroad
- Learning Telehealth Platforms Shows Benefit for Pharmacy Students May 16, 2024Pharmacy graduates must be well-equipped to thrive in various settings, especially in the wake of the pandemic as more avenues to patient care services have emerged.
- May is Hepatitis Awareness Month May 16, 2024Hepatitis Awareness Month is designed to raise awareness of viral hepatitis and promote testing and vaccination while decreasing the stigma against the virus.
Helping You Navigate the Returns Process!
Pedigree Statement
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with it’s clients…
Flash Returns, LLC has strict standard operating procedures and a pharmaceutical services agreement (PSA) with its clients. This is to ensure that the reverse distribution portion of the supply chain that we service keeps its functionality and integrity for our customers and the public.
Several pedigree and distribution level issues have been raised in the industry. Discounted, indigent-pricing, short dated, bulk purchase, secondary distribution, or DSCSA non-compliant sales could affect the credit available for a product based on a manufacturers determination. We ask that you do not return these products for credit as they are not eligible in most cases. Flash Returns LLC may choose to dispose of these on the pharmacies behalf at no charge if the cost is low relative to the return. Most customers purchasing products from reputable wholesalers will not encounter these issues, however all pharmacies are asked to acknowledge our policy on pedigree and legitimacy of product here and by signing the PSA before a return is initiated.
Some manufacturers may require proof the price paid for a product and what wholesaler distributed the product. Issues causing triggering this could be: bulk or large quantities of single items or lots, or products purchased speculatively. In some cases we may request invoices from the customer to ensure Flash Returns or manufacturer policy is being met. If none are available or if the information isn’t accepted by the manufacturer it could cause the return to be non-returnable.
Flash Returns, LLC cannot guarantee or be liable for the value or credit for products that were purchased outside of manufacturer accepted distribution channels. This could include products: purchased from a wholesaler that is not an approved vendor, products not purchased directly from a particular manufacturer, purchased on a speculative basis, diverted or counterfeit products, foreign products, and any product purchased on a non-returnable basis, including short-dated product purchased at discounted pricing.
At any time, Flash Returns, LLC or a manufacturer may require invoices or pedigree information demonstrating proof of purchase. If product has been shipped by Flash Returns, LLC or the Customer to a manufacturer or their agent, Flash Returns, LLC cannot guarantee or facilitate the return of product to the Customer. Manufacturers reverse the right to destroy product they deem not credit worthy or suspect. Manufacturers agreeing to return product to customers will do so at the customers expense. Flash Returns, LLC shall not be responsible for reimbursing a Customer for such product.
If Customer is unable to have product returned within 21 days, product is subject to be destroyed without any payment or credit issued to Customer. In any dispute, failure by Customer to provide invoices for a product or pedigree if requested shall release Flash Returns, LLC from any and all liability of products involved in dispute including the full value of the product. More information on drug pedigrees is available on the FDA website at:
Pedigree Statement
P: 833.553.5274
E: SignUp@FlashReturns.com